Frequently Asked Questions from the Webinar:
Deprescribing in Hospice:
Decisions, Discussions, & The Goals of Care
By pioneering hospice physician, Marcia Levetown, MD
Polypharmacy is a common and challenging problem in hospice. It is associated with decreased cognition, falls, and diminished quality of life. Deprescribing is the process of reviewing a patient’s medications to identify and manage those that cause more harm than good.
Get answers to questions about:
- How often to evaluate medications for deprescribing
- The process of weaning a patient from a medication
- Special concerns for patients with alcoholism
Print and share this valuable information with your team!
About the Author
Dr. Marcia Levetown was among the first physicians in the U.S. to be certified in hospice and palliative medicine in 2008. She has been a pioneer in the field since 1994 and is a fellow of the American Academy of Hospice and Palliative Medicine. She has held professorships in internal medicine and pediatrics, has served as the inaugural chair of the Institute of Palliative Care at the Methodist Hospice in Houston, Texas, as regional medical director for Vitas, and served on an IOM Committee. She is a highly sought after speaker and is the author of two books, several chapters in leading PC textbooks, and many articles and national policies on ethics and palliative care topics.
